OSCR Stock Analysis: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$10.85
-0.29 (-2.60%)
▼
5d:
-11.14%
30d:
-20.45%
90d:
-27.23%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: OSCR is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: OSCR is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$25.95
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.11
32.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $10.85, which is considered oversold relative to its 30-day fair value range of $12.16 to $14.01. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.1) compared to its historical average (9.9). Remarkably, the market is currently pricing in an annual earnings decline of 6.7% over the next few years. This pessimistic expectation contrasts with the company's recent 47.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OSCR is in a downtrend. The price is currently testing key support at $10.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.40 (+41.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSCR is in a downtrend. The price is currently testing key support at $10.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.40 (+41.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$12.16 -
$14.01
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding OSCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 41.9% below Wall St target ($15.40)
- WARNING: Recommendation downgraded due to -11.1% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$12.16 -
$14.01
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$10.78
Resistance Level
$14.01
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.06
Wall Street Target
$15.40
(+41.9%)
Revenue Growth (YoY)
17.3%
Earnings Growth (YoY)
47.2%
Profit Margin
-3.8%
Valuation Discount vs History
-6.7% cheaper
PE vs Historical
8.1 vs 9.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.7%
(market-implied from PE analysis)
1-Year Target
$10.12
(-7%)
2-Year Target
$9.44
(-13%)
3-Year Target
$8.81
(-19%)
3-Yr Target (if PE normalizes)
(PE: 8→10)
$10.82
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 114.7%)
$101.53
(+836%)
Base:
(SPY PE: 8.1, Growth: 114.7%)
$36.62
(+238%)
Bear:
(PE: 6.9, Growth: 114.7%)
$31.13
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.1 to 9.9
Stabilization Target:
$13.33
(+22.8%)
PE Expansion Potential:
+22.8%
Share & Embed Analysis
Last updated: March 31, 2026 3:19 AM ET
Data refreshes hourly during market hours. Next update: 4:19 AM
Data refreshes hourly during market hours. Next update: 4:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Mario Schlosser
SELL
23038 shares
2026-01-08
Mario Schlosser
SELL
76962 shares
2026-01-06
Mario Schlosser
SELL
38835 shares
2025-12-24
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$97 | 57 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$339 | 59 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$361 | 49 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$381 | 62 BUY |
|
HUM
Humana Inc |
HOLD
26 analysts |
$212 | 61 BUY |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.
